Log in to save to my catalogue

A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vul...

A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vul...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7786148

A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse

About this item

Full title

A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Psychopharmacology, 2021-04, Vol.238 (4), p.1029-1046

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Rationale
Opioid use disorder (OUD) is a major epidemic in the USA. Despite evidence indicating that OUD may be particularly severe for women, preclinical models have yet to establish sex as a major factor in OUD.
Objectives
Here, we examined sex differences in vulnerability to relapse following intermittent access fentanyl self-administra...

Alternative Titles

Full title

A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7786148

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7786148

Other Identifiers

ISSN

0033-3158,1432-2072

E-ISSN

1432-2072

DOI

10.1007/s00213-020-05750-2

How to access this item